SCM
ELGX

Sio Capital Management’s Endologix Inc ELGX Stock Holding History

Sio Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-49,306
Closed -$2.4M – 78
2017
Q2 		$2.4M Buy
+49,306
New +$2.9M 1.14% 37

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sio Capital Management's ELGX Position: Q3 2017 in Review

Sio Capital Management sold out of Endologix Inc (ELGX) in Q3 2017, closing a stake of 49,306 shares — an estimated $2.4M sold.

Sio Capital Management first reported a position in ELGX in Q2 2017 and held it in 1 quarter. The position peaked at $2.4M in Q2 2017. 106 funds tracked by Wall St. Rank hold ELGX as of Q3 2017.

  • Sio Capital Management reported no remaining Endologix Inc position as of Q3 2017 after selling out during the quarter.
  • Sio Capital Management sold 49,306 Endologix Inc shares in Q3 2017, an estimated $2.4M.
  • Sio Capital Management first reported a position in Endologix Inc in Q2 2017 and held it in 1 quarter.
  • Sio Capital Management's Endologix Inc position peaked at $2.4M in Q2 2017.
  • 106 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2017.

Based on Sio Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.